Molly Brady brings 15 years of experience to her work in infectious diseases, with a focus on strategy development and monitoring and evaluation (M&E) of neglected tropical diseases (NTDs). She is an expert on lymphatic filariasis (LF), also known as elephantiasis, a mosquito-borne illness that causes disfiguring swelling of limbs and genitals. As senior advisor for NTDs, she provides technical assistance to LF-endemic countries on a range of programmatic areas, including mapping, achieving coverage targets for mass drug administration, and documenting evidence towards elimination of LF as a public health problem.
Ms. Brady serves as senior manager on ENVISION, USAID's flagship project aiming at the control and elimination of seven NTDs by the year 2020. Most recently, she has made significant contributions to the development of global tools for addressing LF morbidity, helping countries to effectively locate and treat individuals living with conditions such as elephantiasis and hydrocele. She is a member of the World Health Organization (WHO) Core Group on LF Morbidity Management and Disability Prevention and Chair of the LF Non-governmental Development Organization (NGDO) Network.
Before joining RTI International, Ms. Brady worked as a technical officer at WHO’s headquarters in Geneva, Switzerland, and in the WHO Western Pacific Regional Office, finalizing global and regional guidelines, regional action plans, and monitoring and evaluation frameworks. She also spent three years supporting USAID's Asia regional office in Bangkok, Thailand, monitoring more than 18 avian influenza program partners working in Burma, China, Laos, Vietnam, and regionally.